Please enable JS

DISCOVER
OUR NEWS

News

FDA’s Drug Safety Priorities for 2023

February 29, 2024

Bio Pharm International FDA’s Drug Safety Priorities FY23 describes the center’s key safety programs and activities involved in promoting and protecting public health. On Feb. 15, 2024, FDA’s Center for Drug Evaluation and Research (CDER) released its report, Drug Safety Priorities FY23. The report describes the center’s key safety programs and activities involved in promoting and […]

READ MORE

News

Unlocking the Pathway Puzzle: How Biopharma Can Navigate the Clinical Pathways Landscape

February 29, 2024

Fierce Biotech In the realm of oncology, the advent of clinical pathways has gained substantial traction in the past two decades as the increasing cost and complexity of cancer care demanded structured, multidisciplinary, and cost-effective approaches. Pathways have become a critical strategy for both physicians and payers to streamline treatment decision-making, standardize evidence-based care, improve patient outcomes […]

READ MORE

News

Clinical Trial Matching Solutions: Understanding the Landscape

February 29, 2024

Applied Clinical Trials Online A framework to understand the different approaches of trial matching solutions and the major operational and workflow challenges that all matching solutions share. The idea of using technology to find patients who meet the eligibility criteria for clinical trials sounds straightforward. A patient or caregiver should be able to find a […]

READ MORE

News

How Are Healthcare AI Developers Responding to WHO’s New Guidance on LLMs?

January 31, 2024

Med City News This month, the World Health Organization released new guidelines on the ethics and governance of large language models (LLMs) in healthcare. Reactions from the leaders of healthcare AI companies have been mainly positive. In its guidance, WHO outlined five broad applications for LLMS in healthcare: diagnosis and clinical care, administrative tasks, education, […]

READ MORE

Categories

News